← Back to Clinical Trials
Recruiting NCT07054866

NCT07054866 Rural Autistic Individuals - Supporting Expression

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07054866
Status Recruiting
Phase
Sponsor Montana State University
Condition Autism Disorder
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-07
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 2 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Speech-Gesture combinations

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-07 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This research study investigates how hand gestures can support language comprehension and communication skills of hearing speaking, non-speaking, and/or minimally verbal individuals with Autism Spectrum Disorders (ASD), who are especially disadvantaged by the lack of accessible services in their rural communities. Individuals with other cognitive profiles, including Developmental Language Disorder (DLD), ADHD, Dyslexia, and others are welcome too. The study uses methods of eye tracking and recording of brain activity to understand how hand gestures adapted from signs from American Sign Language, such as \[cry\], can promote successful understanding of words like "cry". The overarching goal is to help families effectively utilize gestures to support communication with their children.

Eligibility Criteria

Inclusion Criteria: * 1.1 Confirmed (preferably) or suspected diagnosis of ASD (autism spectrum disorder), or a receptive language impairment (i.e., difficulties with comprehension, Developmental Language Disorder), or both. Additional diagnoses, including ADHD (Attention Deficit and Hyperactivity Disorder), are acceptable. Siblings and cousins of these individuals are also welcome. OR 1.2 No diagnoses of ASD or DLD for unrelated control typically-developing participants. 2\. Normal hearing and normal vision (or corrected to normal with glasses or contacts). 3\. Ages 2+. 4. English as the dominant language of caregivers. 5. Caregivers who self-identify as living in a rural area. 6. The ability to verbally or physically respond is optional. Exclusion Criteria: * 1\. Poor hearing. 2. Inborn or acquired brain damage.

Contact & Investigator

Central Contact

Nadya N Modyanova, Ph.D.

✉ language-research@montana.edu

📞 406-848-1535

Frequently Asked Questions

Who can join the NCT07054866 clinical trial?

This trial is open to participants of all sexes, aged 2 Years or older, studying Autism Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07054866 currently recruiting?

Yes, NCT07054866 is actively recruiting participants. Contact the research team at language-research@montana.edu for enrollment information.

Where is the NCT07054866 trial being conducted?

This trial is being conducted at Bozeman, United States.

Who is sponsoring the NCT07054866 clinical trial?

NCT07054866 is sponsored by Montana State University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology